Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Cytovia presents new series of caspase activators and apoptosis inducers

July 4, 2001

Nippon Shinyaku to market and distribute DepoCyt in Japan

July 4, 2001

Gene and cell cycle effects elucidated for NB-1011

July 4, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

July 3, 2001

ImClone Systems begins fast track approval process for colorectal cancer agent

July 3, 2001

Liver-targeted complexes of cisplatin and bile acids designed by Spanish group

July 3, 2001

FDA grants fast track designation for irofulven in pancreatic cancer

July 2, 2001

Mode of action of Oxigene's CA4P supported by preclinical data

July 2, 2001

Matrix commences new phase II IntraDose study for primary liver cancer

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...